Haemostasis and thrombosis Flashcards

1
Q

What is haemostasis?

A

Essential physiological process.

Blood coagulation prevents excessive blood loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is thrombosis?

A

Pathophysiological process.

Blood coagulates within blood vessels and obstructs blood flow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the procoagulants (plasma clotting factors)?

A

Prothrombin
Factors V, VII-XIII
Fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the anticoagulants (plasma clotting factors)?

A

Plasminogen
TFPI (tissue factor pathway inhibitor)
Proteins C and S
Antithrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is atherosclerosis?

A

Pathophysiological process.

Thrombus forms within atherosclerotic plaque.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When may a clot become life-threatening?

A

If it dislodges from the vessel- embolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a feature of venous thromboses?

A

High fibrin components
High erythrocyte content
(Red thrombi)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a feature of arterial thromboses?

A

High platelet components
High lipid content
(White thrombi)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why does a thrombus form?

A

Virchow’s triad.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Virchow’s triad?

A

Rate of blood flow.
Consistency of blood.
Blood vessel wall integrity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the cell-based theory of coagulation?

A

Three stages: initiation, amplification, propagation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is involved in the initiation stage of the cell-based theory of coagulation?

A

Small scale production of thrombin.
Tissue factor bearing cells activate factors X and V, forming prothrombinase complex.
Prothrombinase complex activates factor II (prothrombin) creating factor IIa (thrombin).
Antithrombin (AT-III) inactivates factors IIa and Xa.
Anticoagulants work here.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is involved in the amplification stage of the cell-based theory of coagulation?

A

Large scale thrombin production on the surface of platelets.
Factor IIa (thrombin) activates platelets.
Activated platelets change shape and become ‘sticky’, attaching other platelets.
Antiplatelets work here.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is involved in the propagation stage of the cell-based theory of coagulation?

A

Thrombin mediated generation of fibrin strands from fibrinogen.
Activated platelets are involved in large-scale thrombin production.
Thrombolytics work here.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the constituents of blood?

A
Blood cells (45%)- 99% erythrocytes.
Blood plasma (55%)- 90% water.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does the rate of blood flow affect the risk of thrombus formation?

A

If blood flow is slow/stagnating, there is slow turnover of clotting factors- no replenishment of anticoagulant, balance adjusted in favour of coagulation.
e.g. long haul flight, DVT.
Increased likelihood of thrombus formation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does the consistency of blood affect the risk of thrombus formation?

A

Natural imbalance between pro-coagulation and anticoagulation factors, e.g. factor V leiden.
Increased likelihood of thrombus formation.

18
Q

How does the blood vessel wall integrity affect the risk of thrombus formation?

A

Damaged endothelia leads to blood being exposed to pro-coagulation factors. Increased likelihood of thrombus formation.

19
Q

What is dabigatran?

A

Factor IIa inhibitor
Oral
Inhibits initiation phase of cell-based theory of coagulation.

20
Q

What is rivaroxaban?

A

Factor Xa inhibitor
Oral
Inhibits initiation phase of cell-based theory of coagulation.

21
Q

What is heparin?

A

Activates AT-III (decreased factors IIa and Xa)
i.v., s.c.
Inhibits initiation phase of cell-based theory of coagulation.

22
Q

What are low molecular weight heparins?

A

Activate AT-III (decreased Xa)
e.g. dalteparin
Inhibits initiation phase of cell-based theory of coagulation.

23
Q

What is warfarin?

A

Vitamin K antagonist
Vitamin K is required for generation of factors II, VII, IX and X.
Oral
Inhibits initiation phase of cell-based theory of coagulation.

24
Q

List anticoagulant drugs.

A

Dabigatran
Rivaroxaban
Heparin
Low molecular weight heparins, e.g. dalteparin
Warfarin
These inhibit initiation phase of cell-based theory of coagulation.

25
Q

What are the indications for anticoagulant use?

A

Venous thrombosis
DVT and pulmonary embolism
Thrombosis during surgery
Atrial fibrillation- prophylaxis of stroke

26
Q

How does platelet activation occur?

A

Thrombin binds to protease-activated receptor (PAR) on platelet surface.
PAR activation leads to a rise in intracellular calcium.
Calcium rise leads to exocytosis of ADP from dense granules.
ADP activates P2Y receptors, leading to platelet activation/aggregation.
PAR activation liberates arachidonic acid.
COX generates thromboxane A2 from arachidonic acid.
Thromboxane A2 activation leads to expression of GPIIb/IIIa integrin receptor on platelet surface. GPIIb/IIIa is involved in platelet aggregation.

27
Q

What is clopidogrel?

A

ADP (P2Y) receptor antagonist.
Oral
Prevents platelet activation/aggregation.
Inhibits amplification phase of cell-based theory of coagulation.

28
Q

What is aspirin?

A

Irreversible COX-1 inhibitor.
Oral
Inhibits production of thromboxane A2.
Inhibits amplification phase of cell-based theory of coagulation.

29
Q

What is abciximab?

A

Prevents platelet aggregation.
i.v., s.c.
Limited use, only by specialists.
Inhibits amplification phase of cell-based theory of coagulation.

30
Q

List anti-platelet drugs.

A

Clopidogrel
Aspirin
Abciximab

31
Q

What are the indications for anti-platelet drug use?

A

Arterial thrombosis
Acute coronary syndromes- myocardial infarction
Atrial fibrillation- prophylaxis of stroke

32
Q

What is the mechanism of thrombolytic drug action?

A

Convert plasminogen to plasmin.
Anticoagulants and anti-platelets do not remove pre-formed clots.
Plasmin- protease degrades fibrin.

33
Q

Name a thrombolytic drug.

A

Alteplase
A recombinant tissue type plasminogen activator (rt-PA)
i.v.

34
Q

What are the indications for thrombolytic drug use?

A

Arterial and venous thrombosis
Stroke- first-line treatment
ST-elevated MI

35
Q

What causes DVT and pulmonary embolism?

A

Decreased rate of blood flow

Damage to endothelium

36
Q

How is DVT and PE managed?

A

Restore balance between coagulants and anticoagulants.
Decrease levels of anticoagulant factors
Use anticoagulant drugs.

37
Q

What is NSTEMI?

A

Non-ST elevated myocardial infarction.
Acute coronary syndrome.
White thrombus- partially occluded coronary artery.

38
Q

What causes NSTEMI?

A

Damage to endothelium
Atheroma formation
Platelet aggregation

39
Q

What is STEMI?

A

ST elevated myocardial infarction.
Acute coronary syndrome.
White thrombus- fully occluded coronary artery.

40
Q

What causes STEMI?

A

Damage to endothelium
Atheroma formation
Platelet aggregation

41
Q

How is NSTEMI managed?

A

Prevent further arterial occlusion.
Decrease platelet activation/aggregation.
Anti-platelets.

42
Q

How is STEMI managed?

A

Prevent death.
Decrease platelet activation/aggregation.
Dissolve clot.
Anti-platelets and thrombolytics.